CCN3 promotes prostate cancer bone metastasis by modulating the tumor-bone microenvironment through RANKL-dependent pathway.
about
Investigating microenvironmental regulation of human chordoma cell behaviourProstate cancer-derived CCN3 induces M2 macrophage infiltration and contributes to angiogenesis in prostate cancer microenvironment.Matricellular proteins as regulators of cancer metastasis to bone.The CCN family proteins: modulators of bone development and novel targets in bone-associated tumorsPolycomb-Mediated Disruption of an Androgen Receptor Feedback Loop Drives Castration-Resistant Prostate Cancer.Bone microenvironment signals in osteosarcoma development.Nephroblastoma overexpressed gene expression and its prognostic implications of clinical outcomes in renal cell carcinoma patients.Expression array analysis of the hepatocyte growth factor invasive program.Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.CCN3 promotes epithelial-mesenchymal transition in prostate cancer via FAK/Akt/HIF-1α-induced twist expression.CCN3 is a therapeutic target relating enhanced stemness and coagulation in hepatocellular carcinoma.Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.Effect of L-Caldesmon on Osteoclastogenesis in RANKL-Induced RAW264.7 Cells.
P2860
Q33275485-771A2845-A7F3-4206-B8D5-51F27A25F416Q33688940-6ECD0E10-FD62-4E96-B781-ED1796664F10Q36923653-CBAB3696-2A28-451D-9B39-3D8FA95E231CQ37557267-E30692F6-B4BB-48C6-8538-82AF477AE079Q37592443-7B3C62A1-E26F-496D-ADAA-CA296C787075Q38454980-3102FFC4-CF62-4E1E-86D7-8CB38EE4F5A8Q38628825-E5A6B5D7-D22C-4F63-AA44-C7D944A76736Q38847534-C5A6BFED-521D-4634-A774-C26019EAE856Q40977712-01CD0753-30AF-45CD-BDD9-4F8E70D91EBCQ47095922-BD17C767-81F9-4D52-BDCC-B883E11B03C5Q47123384-B85B55DD-007A-4F90-B454-E9C02D7741DAQ47146670-A1A066FC-FD99-4C6F-B21D-63F7C9D83CEBQ49611769-38D605D7-DF02-4F89-AB81-61D32F250ACE
P2860
CCN3 promotes prostate cancer bone metastasis by modulating the tumor-bone microenvironment through RANKL-dependent pathway.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
CCN3 promotes prostate cancer ...... rough RANKL-dependent pathway.
@en
CCN3 promotes prostate cancer ...... rough RANKL-dependent pathway.
@nl
type
label
CCN3 promotes prostate cancer ...... rough RANKL-dependent pathway.
@en
CCN3 promotes prostate cancer ...... rough RANKL-dependent pathway.
@nl
prefLabel
CCN3 promotes prostate cancer ...... rough RANKL-dependent pathway.
@en
CCN3 promotes prostate cancer ...... rough RANKL-dependent pathway.
@nl
P2093
P2860
P356
P1433
P1476
CCN3 promotes prostate cancer ...... rough RANKL-dependent pathway.
@en
P2093
Chih-Hsin Tang
Hsu-Chen Cheng
Po-Chun Chen
P2860
P304
P356
10.1093/CARCIN/BGT103
P407
P577
2013-03-27T00:00:00Z